Conferences

Conference data for March 31, 2020: ACC.20/WCC Virtual

March 31, 2020

New and updated preclinical and clinical data presented by biopharma firms at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC Virtual), including: Amarin, Mesoblast, Resverlogix.

Conference data for March 30, 2020: ACC.20/WCC Virtual

March 30, 2020

No Comments

New and updated preclinical and clinical data presented by biopharma firms at the American College of Cardiology’s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC Virtual), including: Astrazeneca, Cytokinetics, Esperion, Janssen, Kiniksa, Merck, Mesoblast, Novartis, Regeneron.

Bio-Europe Spring 2020

Conferences go virtual, postpone, as COVID-19 spreads and Bio-Europe Spring wraps up

March 27, 2020

By Karen Carey

No Comments

The five-day Bio-Europe Spring 2020 conference, possibly the first ever life sciences partnering event staged in an all-virtual format, ended on Friday, March 27, with high hopes that the industry would return to face-to-face interactions next year in Barcelona.

Bio-Europe Spring 2020

Closing panel offers COVID-19 lessons to learn from China

March 27, 2020

By Karen Carey

No Comments

Biopharma industry leaders in China who were the first to experience the chaos of the COVID-19 pandemic shared their thoughts during a closing plenary session of the virtual Bio-Europe Spring 2020 meeting.

Bio-Europe Spring 2020

Partnering plows through a pandemic with the restaged virtual Bio-Europe Spring conference

March 25, 2020

By Karen Carey

No Comments

At the beginning of this week, the digitally-delivered Bio-Europe Spring 2020 conference launched with 6,000 partnering meetings, 45 company presentations, more than 50 virtual exhibits and 12 panel discussions scheduled.

Bio-Europe Spring 2020

Interrupting disease by plugging into the grid and pulling down innovation

March 24, 2020

By Karen Carey

No Comments

Before becoming the global head of Johnson & Johnson External Innovation, William Hait spent 30 years in academic medicine focused on oncology. Whenever he speaks to a group, the first question he asks is if there is anyone in the room that would like to get a disease.

Bio-Europe 2020

Seventure leads think-in on microbiome dealmaking

March 24, 2020

By Cormac Sheridan

No Comments

DUBLIN – Bio-Europe Spring’s virtual panel on the partnering dynamic between big pharma and microbiome-focused biotech firms was essentially an in-house webinar hosted by Seventure Partners, a Paris-based venture capital fund that has led the way in investing in microbiome-related therapeutics, diagnostics and other products.

Bio-Europe Spring 2020

Moving in record time, industry, government, investors focus on one mission: Beat COVID-19

March 23, 2020

By Karen Carey

No Comments

Business as usual only three months ago has transformed into health care industry overdrive as biopharma and med-tech companies scramble to test and scale-up treatments, vaccines and diagnostics to address COVID-19.

Bio-Europe Spring 2020

Hunting for niches in cardiometabolic disease, as Secarna passes dyslipidemia milestone

March 23, 2020

By Cormac Sheridan

No Comments

DUBLIN – For quite some time, cardiometabolic disease has been largely off the map for most small biotechs and for the venture capital investors that support them. Is that situation about to change? Maybe, maybe not was the mixed message arising from a Bio-Europe Spring 2020 virtual panel discussion on cardiometabolic disease.

CROI 2020

For beating HIV, how good is best?

March 12, 2020

By Annette Boyle

No Comments

Like Berlin patient Timothy Ray Brown before him, London patient Adam Castillejo, whose case was top story of the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), energized the HIV cure research field by his sheer existence. Curing HIV, Pablo Tebas told the audience at a themed discussion on curative strategies, “has been considered [for] a long time the holy grail.”

Conferences, BioWorld
RSS

Conference data for March 31, 2020: ACC.20/WCC Virtual

Conference data for March 30, 2020: ACC.20/WCC Virtual

Conferences go virtual, postpone, as COVID-19 spreads and Bio-Europe Spring wraps up

Closing panel offers COVID-19 lessons to learn from China

Partnering plows through a pandemic with the restaged virtual Bio-Europe Spring conference

Interrupting disease by plugging into the grid and pulling down innovation

Seventure leads think-in on microbiome dealmaking

Moving in record time, industry, government, investors focus on one mission: Beat COVID-19

Hunting for niches in cardiometabolic disease, as Secarna passes dyslipidemia milestone

For beating HIV, how good is best?

Popular Stories

South Korea approves first four COVID-19 test kits under urgent-use license

Two South Korean COVID-19 kits look overseas, seek FDA approval

Noninvasive ventilation options explored for COVID-19, as FDA eases with guidance

FDA says yes to NO: Bellerophon Therapeutics wins expanded access approval for inhaled nitric oxide system

Antiviral favipiravir effective against COVID-19, China says

BioWorld Premium

Conferences, BioWorld RSS

Popular Stories

BioWorld Premium

Conferences, BioWorld
RSS